NSRX — Nasus Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapValue Trap

Annual balance sheet for Nasus Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2022 March 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS
Standards:	USG	USG	USG
Status:	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0	0	0
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0	0	0
Other Long Term Assets
Total Assets	0	0	0.001
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.003	0.004	0.004
Total Long Term Debt
Total Debt
Total Liabilities	0.003	0.004	0.004
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	-0.003	-0.004	-0.003
Total Liabilities & Shareholders' Equity	0	0	0.001
Total Common Shares Outstanding